Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jonathan Farhi
Observed name:
J. Farhi
Institution:
Centre Hospitalier Universitaire d'Angers
Observed institutions:
Institut Gustave Roussy,
Centre Hospitalier Universitaire d'Angers,
Hôpital Pontchaillou,
Centre Hospitalier du Mans,
Centre Hospitalier Universitaire de Rennes,
Université d'Angers
show all 6
ORCID:
0000-0001-8382-0140
Observed ORCID:
0000-0001-8382-0140
OpenAlex ID:
A5055914790
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
2019
·
Emmanuel Bachy
, John F. Seymour
, et al.
·
Journal of Clinical Oncology
·
414
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies
2016
·
Kamel Laribi
, Nathalie Denizon
, et al.
·
Transplantation and Cellular Therapy
·
59
Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin’s lymphoma undergoing allogeneic haematopoietic cell transplantation—a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
2018
·
Jordan Gauthier
, Xavier Poiré
, et al.
·
Bone Marrow Transplantation
·
46
PDF
R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma
2016
·
Kamel Laribi
, Nathalie Denizon
, et al.
·
Annals of Hematology
·
41
Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers
2017
·
Nicolas Vallet
, Flore Sicre de Fontbrune
, et al.
·
Haematologica
·
26
Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care
2016
·
Corentin Orvain
, Francois Beloncle
, et al.
·
Transplantation
·
26
Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma
2018
·
Jonathan Farhi
, Kamel Laribi
, et al.
·
Annals of Hematology
·
22
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence
2018
·
Corentin Orvain
, Francois Beloncle
, et al.
·
Annals of Hematology
·
20
The bendamustine plus rituximab regimen is active against primary nodal marginal zone B‐cell lymphoma
2016
·
Kamel Laribi
, Adrien Tempescul
, et al.
·
Hematological Oncology
·
19
Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study
2016
·
C. Orvain
, D. Luque Paz
, et al.
·
Annals of Hematology
·
18
Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease
2023
·
Marie-Camille Lafargue
, Mickaël Bobot
, et al.
·
Kidney International Reports
·
10
PDF
Impact of the relative dose intensity on survival of patients with high‐risk myelodysplastic syndromes treated with Azacitidine
2019
·
Kamel Laribi
, Delphine Bolle
, et al.
·
Cancer Medicine
·
10
PDF
Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine
2018
·
Kamel Laribi
, Delphine Bolle
, et al.
·
Experimental Hematology
·
9
Significant impact of immunosuppression on the incidence of secondary malignancies following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with indolent B-cell neoplasms
2018
·
Nathalie Denizon
, Alix Baugier de Materre
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
9
Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement
2021
·
Mélanie Mercier
, Corentin Orvain
, et al.
·
Cancers
·
3
PDF
R‐DHA‐oxaliplatin (R‐DHAOx) versus R‐DHA‐cisplatin (R‐DHAP) regimen in B‐cell lymphoma treatment: A eight‐year trajectory study
2020
·
Carole Lacout
, Corentin Orvain
, et al.
·
European Journal Of Haematology
·
3
BRAF V600E Targetable Mutation in Relapsed/Refractory Multiple Myeloma (R/R MM) Patients: A High Incidence in R/R MM Detected Using Cell Sorting Screening
2016
·
Alina Danu
, Sophie Cotteret
, et al.
·
Blood
·
3
R-DHA-Oxaliplatin Versus R-DHA-Cisplatin Regimen in B-Cell Nhl's Treatment: A Eight Years Retrospective Study
2015
·
Carole Lacout
, Manon De Vries
, et al.
·
Blood
·
2
Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis
2026
·
Carole Mosnier
, Marie-Christine Copin
, et al.
·
Leukemia
·
1
PDF
Durable Responses With Front‐Line Rituximab in Autoimmune Cytopenias Associated With Indolent B‐Cell Clones
2025
·
Yoann Zadro
, Amélie Lusque
, et al.
·
American Journal of Hematology
·
1
PDF
Autoimmune Cytopenia Associated with Indolent B-Cell Clones: A Large Multicentric Cohort Study
2023
·
Yoann Zadro
, Amélie Lusque
, et al.
·
Blood
·
1
PDF
Lymphoplasmacytic lymphoma or multiple myeloma: immunoglobulins may lead to misdiagnosis
2018
·
Jérôme Debus
, Pierre Lemaire
, et al.
·
Annales de biologie clinique
·
1
Cytopénies auto-immunes associées aux hémopathies lymphoïdes B indolentes : une étude de cohorte multicentrique française
2023
·
Y. Zadro
, A. Lusque
, et al.
·
La Revue de Médecine Interne
#2664 Chronic Myelomonocytic Leukemia (cmml) Patients With Lysozyme Nephropathy and Cmml Renal Infiltration Display Markers of Severe Disease
2023
·
Marie-Camille Lafargue
, Jean-Paul Duong Van Huyen
, et al.
·
Nephrology Dialysis Transplantation
PDF
Atteintes rénales au cours de la leucémie myélomonocytaire chronique : néphropathie au lysozyme et infiltration rénale par la LMMC, marqueurs de mauvais pronostic
2023
·
M.C. Lafargue
, J.P. Duong Van Huyen
, et al.
·
La Revue de Médecine Interne
Show more works
View as search
Works count:
27
Citation count:
747
H-index:
10
I10-index:
12
Year
Topic
Type